Eisai Co., Ltd. - The Parent Company

The story of Eisai Co., Ltd (“Eisai”) began even before it bore its current name, when its entrepreneurial founder Toyoji Naito launched his pharmaceutical career by marketing imported drugs to the Japanese public in the early 20th century. His inexhaustible drive to improve the people’s access to groundbreaking medicine continues to permeate all aspects of Eisai’s operations globally, and as the company continues to expand its reach to many communities in need, its pioneering hhc (“human health care”) philosophy remains its core guiding principle.

Formally established in 1941 and headquartered in Tokyo, Japan, Eisai has since grown to become a leading global research and development-based pharmaceutical company, operating over 40 subsidiaries and employing more than 10,000 employees worldwide. Its continued commitment to improve lives is grounded in rigorous scientific research and its hhc philosophy, which emphasises the need for all its employees to spend 1% of their working hours with patients.

Owing to its founder’s early ambition to source and develop effective medicine to combat widespread ailments, Eisai is thus resolute in its mission to assist many communities in need worldwide by banking on its strategic partnerships and existing expertise to rapidly improve healthcare infrastructure and access. Having established neurology and oncology as areas of focus, Eisai aims to tackle diseases for which treatments are yet to be fully available. By actively concentrating R&D resources in these areas, Eisai continues to dedicate itself to discovering new and highly effective treatments. Eisai is a publicly traded company on the Tokyo Stock Exchange.

Eisai In Numbers

Ensuring our 1 true goal of placing our patients and their families first above all else is actualised across all our operations.

15

Operating 15 drug discovery, research and development, clinical research sites.

40

Overseeing more than 40 subsidiaries worldwide.

80

Improving lives for over 80 years.

> 10,000

More than 10,000 employees worldwide

645.9 bil

Generated 645.9 billion in revenue (FY2020).

15

Operating 15 drug discovery, research and development, clinical research sites.

40

Overseeing more than 40 subsidiaries worldwide.

80

Improving lives for over 80 years.

> 10,000

More than 10,000 employees worldwide

645.9 bil

Generated 645.9 billion in revenue (FY2020).

Eisai (Malaysia) Sdn Bhd - A Subsidiary

A pharmaceutical subsidiary of Eisai Co., Ltd., Eisai Malaysia celebrated its golden jubilee in 2019 to mark the corporation’s presence and growth in the country since 1969. Inspired by the history and expansion of its parent company in Japan, Eisai Malaysia continues to champion and advocate for universal access to innovative medicines.

Eisai Malaysia is steadfast in its commitment to be the pioneering hhc company in the nation, firm in the belief that the people’s health cannot be approached as a mere statistic, but as a holistic experience that is capable of transforming communities, beyond healing the individual patient. To that end, Eisai Malaysia is indebted to the selfless and unsung heroes who have helped to grow the company’s
influence and outreach, allowing previously untapped communities to benefit its scientific endeavours.

Eisai Malaysia looks forward to continuing its strategic collaborations with stakeholders and partners, including healthcare providers, to fulfil its corporate objective for the next 50 years and beyond.

Corporate Philosophy

We give first thought to patients and their families, and to increasing the benefits health care providers.

We are, first and foremost, a company for the people. Eisai Malaysia has always been principally guided by the belief that innovative healthcare solutions should always be readily accessible by all who need them, which is why we’ll continue to leverage on our extensive network and expertise to elevate the human health care experience in the nation.

Corporate Objective

A human health care company capable of making meaningful contributions under any healthcare system while observing the highest legal and ethical standards in business activities.

We aspire to be a socially and environmentally conscious enterprise, and the key to that is to ultimately create a sustainable society well equipped with the necessary resources for efficient disease management.

Charter of Business Conduct of Eisai Network Companies.

Charter of Business Conduct of Eisai Network Companies

Established: March 2000

Revised: March 2021

We give first thoughts to patients and their families. We strive to increase the benefits that healthcare provides them and we conduct our business to meet their diversified healthcare needs worldwide. As a human health care (“hhc”) company, we develop and provide products and services that contribute to the well-being of patients and customers under any healthcare system.

In order to realize our corporate philosophy, we develop business activities that contribute to sustainable economic growth and the resolution of social issues, as well as make decisions and act appropriately and in a timely manner, in compliance with all relevant laws and ethical standards.

We hereby establish our Charter of Business Conduct as a statement of our commitment to compliance. Compliance is essential to the company’s existence and is given top priority in all corporate activities. Corporate executives recognize that it is their role to lead the employees by implementing the content and spirit of this Charter in all the work they do and in supervising those who work with them. By adhering to this Charter, they will inspire and encourage everyone to apply these standards in all their activities.

Everyone is expected to abide by the content and spirit of this Charter.

We promote mutual respect and trust in our business relationships with our stakeholders including patients,
customers, shareholders, investors, employees, healthcare providers, business partners and communities.
We compete fairly, and do not tolerate bribery or any other form of corrupt business behavior.
We appropriately manage information and ensure our records are accurate, complete, fair and secure.
We appropriately disclose corporate information in a timely manner, and communicate with stakeholders transparently.
We act in the workplace in accordance with the principles of fairness, respect, and non-discrimination with respect for diversity.
We provide a work environment that takes health and safety into consideration.
We comply with all relevant laws and regulations of each jurisdiction in which we do business and we conduct ourselves with the highest sense of ethics.
We respect human rights and do not tolerate, within the scope of our business and in our supply chain,
modern slavery such as child labor, forced labor and human trafficking.
As a “good corporate citizen,” we contribute to the resolution of social issues and the development of society.
We maintain fair and transparent relations with political and government entities.
We shall not enter into, or to the extent we become aware we shall sever, relations with organized crime groups.
We place global environmental protection as an important component of business operations and strive to maintain the environment.

Press Release

January 22, 2024

EISAI (MALAYSIA) SDN. BHD. PARTNERS WITH TOKIO MARINE INSURANS (MALAYSIA) BERHAD AND PMCARE SDN. BHD. TO ENHANCE ACCESS TO ALZHEIMER'S DISEASE TREATMENTS AND PROMOTE AWARENESS OF AD, DEMENTIA, AND BRAIN HEALTH IN MALAYSIA

January 22, 2024

Eisai (Malaysia) Sdn. Bhd. Partners with Tokio Marine Insurans (Malaysia) Berhad and PMCare Sdn. Bhd. to Enhance Access to Alzheimer's Disease Treatments and Promote Awareness of AD, Dementia, and Brain Health in Malaysia

Eisai (Malaysia) Sdn. Bhd. (Eisai), a sales subsidiary of Japan-based pharmaceutical company Eisai Co., Ltd., under the leadership of Managing Director Ms. Kam Ai Teng, proudly announces the signing of a Memorandum of Understanding with Tokio Marine Insurans (Malaysia) Berhad (Tokio Marine) and PMCare Sdn. Bhd. (PMCare), which collaborates on promoting disease awareness activities, and developing solutions for improving affordability of Alzheimer’s disease (AD) management in Malaysia.

Eisai has long been recognized as a pioneering pharmaceutical company dedicated to groundbreaking research and development in the field of AD treatments. Our unwavering commitment extends to efforts to enhance the lives of early-stage AD patients and ensure equal access to high-quality medical care for all.

With a profound commitment to enhancing the quality of life for Malaysia's AD population, Eisai, Tokio Marine, and PMCare are united to confront the mounting challenges posed by the rising prevalence of AD. Our shared mission is to minimize these hurdles and make treatments more readily accessible to the public. Eisai has been at the forefront of AD research to solve these issues for more than 35 years. Our goal for the future is to ultimately prevent disease progression, by engaging new diagnostic methodologies and next-generation treatments.

During the official signing ceremony, Mr. Shohei Kanazawa, Vice President and President of Asia and Latin America Region of Eisai, underscored the significance of this partnership, stating that “Alzheimer's Disease is a growing threat for patients and their families in Malaysia as it imposes burdens not only on patients and their care partners, but also to the society and healthcare system. In Malaysia, an estimated ~260,000 people are living with dementia and more than 90% of elderly people have a low level of awareness of Alzheimer’s Disease ^1,2. This contributes to significant gaps in proactive care. We are honored to be given an opportunity to work hand-in-hand with respectable partners such as Tokio Marine and PMCare. In this partnership, Eisai will leverage our experience and knowledge to drive awareness of dementia and enhance access to diagnosis, treatments, total care for elders and dementia patients and to make a greater impact in this next era of Alzheimer’s Disease care in Malaysia.”

Mr. Masaaki Morimoto, Deputy Chief Executive Officer of Tokio Marine shared his thoughts during the ceremony, saying “Tokio Marine is delighted to celebrate the signing of this significant partnership, which marks a new chapter for the product development team. This milestone would enable us to increasingly create positive impact to the Malaysian society.”

Additionally, Mr. Kamal Aryf, Chief Executive Officer of PMCare, emphasized their commitment, stating "As Malaysia will become an aging society by 2030, PMCare aims to engage with relevant stakeholders to create a network of support and knowledge and generate a high level of sustainable awareness of Alzheimer's Disease and dementia, especially in the potential target population so that no one takes Alzheimer's Disease and dementia for granted. This collaboration with Eisai and Tokio Marine is a big step forward for all of us to enhance the quality of lives of Malaysians affected by Alzheimer's Disease and dementia.."

As part of our joint initiatives, we will further develop medical products to provide patients with enhanced access to the finest treatment options. Concurrently, we will engage in comprehensive disease awareness campaigns aimed at fostering a deeper understanding of AD.

The tripartite partnership between Eisai Malaysia, Tokio Marine, and PMCare aim to provide better quality of life for AD patients and their families in Malaysia.

1. Supporting people living with dementia in Malaysia. WHO, (2022), https://www.who.int/westernpacific/news- room/feature-stories/item/supporting-people-living-with-dementia-in-malaysia.

2. Ali, M et al (2023). Dementia awareness among elderly at risk for developing mild cognitive impairment: A cross-sectional study at a university-based primary care clinic. BMC Geriatrics, 23, 496.

1. About Eisai Co., Ltd.

Eisai's Corporate Concept is "to give first thought to patients and people in the daily living domain, and to increase the benefits that health care provides." Under this Concept (also known as human health care (hhc) Concept), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to create and deliver innovative products to target diseases with high unmet medical needs, with a particular focus in our strategic areas of Neurology and Oncology.

In addition, we demonstrate our commitment to the elimination of neglected tropical diseases (NTDs), which is a target (3.3) of the United Nations Sustainable Development Goals (SDGs), by working on various activities together with global partners.

For more information about Eisai, please visit www.eisai.com (for global headquarters: Eisai Co., Ltd.). and connect with us on X, LinkedIn and Facebook.

2. About Tokio Marine Insurans (Malaysia) Berhad

Tokio Marine Insurans (Malaysia) Berhad or TMIM is a subsidiary of Tokio Marine Asia Pte. Ltd. Singapore and its ultimate holding company is Tokio Marine Holdings Inc., in Japan. The Tokio Marine Group has had more than 140 years history in Japan being the oldest and one of the largest insurance group in Japan. The group is engaged in a wide variety of businesses ranging from non-life insurance to life insurance, international insurance, financial and other general business. The Group operates a worldwide network that spans 46 countries and regions to provide safety and security to customers.

3. About PMCare Sdn. Bhd.

PMCare Sdn. Bhd.'s ("PMCare") purpose is "Enhancing Quality of Life". PMCare aims to be the preferred healthcare management group that creates sustainable healthcare enriching quality of life ("QOL"). PMCare introduces solutions for the healthcare management industry by creating a customer-focused value-based care system leveraging advanced technology and integrated networks throughout the whole spectrum of healthcare. PMCare has the largest panel network of medical providers of more than 6,000 to serve their customers nationwide. For more information about PMCare, please visit www.pmcare.com.my and connect with us on LinkedIn.

Message From The Managing Director

Kam Ai Teng, Managing Director

At Eisai Malaysia, we believe that leadership is nothing without compassion.

To this day, we continue to be inspired by the stories we have heard from those on the medical frontlines and strive to elevate the lives of each and every patient that we have had the fortune to help. By completely embracing our predecessors emphasis on establishing a human health care culture, all of our leaders at Eisai Malaysia persist in encouraging our teams to slow down, listen, and understand the needs of every patient. It only takes a single act of kindness to achieve a breakthrough.

In line with that sentiment, we are dedicated to cultivating a diverse, supportive, and progressive group. After all, the work begins first from within, thus necessitating the need for a conducive working environment that stimulates the collaborative spirit and drives innovation. It is an understatement to say that we are proud of the team we’ve managed to nurture over the years, and who have continued to spread that kindness forward through the state-of-art products we provide.

After all, Eisai is a global leading research-based pharmaceutical company with a focus in neurology and oncology. To say that we are obsessed to discover novel medication and methods to treat enigmatic diseases is an understatement. If anything, we choose to be defined by our relentless pursuit for ground-breaking medicines and effective therapy, all in the name to improve the people’s access to greater healthcare.

Privacy Policy

INTRODUCTION

COLLECTION OF PERSONAL DATA

SOURCES OF PERSONAL DATA COLLECTION

REASONS FOR PERSONAL DATA COLLECTION

PROCESSING OF PERSONAL DATA

DISCLOSURE OF PERSONAL DATA

SECURITY MEASURES

PERSONAL DATA RETENTION PERIOD

YOUR RIGHTS

Contacting Us

AMENDMENTS

ACKNOWLEDGEMENT AND CONSENT

Disclaimer

Terms of Use

Use of Eisai Corporate Website

Eisai at a Glance

Eisai Co., Ltd. - The Parent Company

Eisai In Numbers

15

40

80

> 10,000

645.9 bil

15

40

80

> 10,000

645.9 bil

Eisai (Malaysia) Sdn Bhd - A Subsidiary

Corporate Philosophy

Corporate Objective

Charter of Business Conduct of Eisai Network Companies

Press Release

EISAI (MALAYSIA) SDN. BHD. PARTNERS WITH TOKIO MARINE INSURANS (MALAYSIA) BERHAD AND PMCARE SDN. BHD. TO ENHANCE ACCESS TO ALZHEIMER'S DISEASE TREATMENTS AND PROMOTE AWARENESS OF AD, DEMENTIA, AND BRAIN HEALTH IN MALAYSIA

Eisai (Malaysia) Sdn. Bhd. Partners with Tokio Marine Insurans (Malaysia) Berhad and PMCare Sdn. Bhd. to Enhance Access to Alzheimer's Disease Treatments and Promote Awareness of AD, Dementia, and Brain Health in Malaysia

Message From The Managing Director